Azitra Stock Quote AZTR - Stock Price, News, Charts, Message Board, Trades

Professional-Grade Tools, for Individual Investors.

Premium

Current Price

0.142

Bid

Ask

Volume

5,427,129

0.1307 Day's Range 0.1546

0.1307 52 Week Range 5.18

Market Cap

1.694M

Previous Close

0.1554

Open

0.1546

Last Trade

500

0.142

(formt)

Last Trade Time

18:12:05

Financial Volume

$ 775,911

VWAP

0.142969

Average Volume (3m)

1,844,098

Shares Outstanding

12,097,643

Dividend Yield

PE Ratio

-0.13

Earnings Per Share (EPS)

-1.04

Revenue

686k

Net Profit

-12.64M

Azitra Inc is an early-stage clinical biopharmaceutical company. The Company is focused on developing therapies for precision dermatology using engineered proteins and live biotherapeutic products that can be applied topically to treat diseases of the skin. Its platform includes a microbial library ... Azitra Inc is an early-stage clinical biopharmaceutical company. The Company is focused on developing therapies for precision dermatology using engineered proteins and live biotherapeutic products that can be applied topically to treat diseases of the skin. Its platform includes a microbial library comprised of approximately 1,500 bacterial strains that can be screened for therapeutic characteristics. The platform is augmented by artificial intelligence and machine learning technology that analyzes, predicts and helps screen its library of strains for drug-like molecules. Its product ATR-12 is a genetically modified strain of S. epidermidis for treating the orphan disease, Netherton syndrome, a chronic and fatal disease of the skin. Its product ATR-04 is a genetically modified strain of S. epidermidis for treating the papulopustular rash. Its product ATR-01 is a human filaggrin protein for treating ichthyosis vulgaris, a chronic, xerotic (abnormally dry), and scaly skin disease. Show more

Sector

Pharmaceutical Preparations

Industry

Pharmaceutical Preparations

Website

www.azitrainc.com

Headquarters

Wilmington, Delaware, USA

Founded

1970

Azitra Inc is listed in the Pharmaceutical Preparations sector of the American Stock Exchange with ticker AZTR. The last closing price for Azitra was $0.16. Over the last year, Azitra shares have traded in a share price range of $ 0.1307 to $ 5.18.

Azitra currently has 12,097,643 shares outstanding. The market capitalization of Azitra is $1.69 million. Azitra has a price to earnings ratio (PE ratio) of -0.13.

Form DEF 14A - Other definitive proxy statements

Azitra, Inc. Announces Presentation at the 2024 BIO International Convention

Azitra, Inc. (NYSE American: AZTR), a clinical-stage biopharmaceutical company focused on developing innovative therapies for precision dermatology, today announced that management will present...

Form PRE 14A - Other preliminary proxy statements

Azitra, Inc. Announces Positive Preclinical Data from ATR-04 Presented at the Society of Investigative Dermatology Annual Meeting

ATR-04 is in development for epidermal growth factor receptor inhibitor (EGFRi)-induced dermal toxicity, which affects approximately 150,000 patients in the US Reduces methicillin-resistant S...

Azitra, Inc. Announces Positive Preclinical Data of ATR-12 and Clinical Design in Netherton Syndrome Presented at the ASGCT Annual Meeting

ATR-12 has nanomolar inhibition of key protease in vitro that drives Netherton syndrome Topical application of ATR-12 to ex vivo human skin results in superior LEKTI delivery compared to topical...

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	-0.008	-5.33333333333	0.15	0.2793	0.1307	10846246	0.20507707	CS
4	-0.058	-29	0.2	0.2793	0.1307	3118492	0.19814705	CS
12	-0.063	-30.7317073171	0.205	0.293	0.1307	1844098	0.20431502	CS
26	-1.148	-88.992248062	1.29	2.28	0.1307	1075315	0.22874442	CS
52	-4.858	-97.16	5	5.18	0.1307	537817	0.27593445	CS
156	-4.118	-96.6666666667	4.26	5.18	0.1307	536435	0.2824079	CS
260	-4.118	-96.6666666667	4.26	5.18	0.1307	536435	0.2824079	CS

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
SPECSpectaire Holdings Inc	$ 0.6499 (91.15%)	5.43M
SRPTSarepta Therapeutics Inc New	$ 167.67 (35.77%)	680.42k
LGHLWLion Group Holding Ltd	$ 0.0075 (15.38%)	21.05k
BRNSBarinthus Biotherapeutics PLC	$ 1.44 (15.20%)	2.53k
CODACoda Octopus Group Inc	$ 7.00 (14.75%)	454
RELIReliance Global Group Inc	$ 0.5104 (-15.48%)	1.59M
NTBLNotable Labs Ltd	$ 0.6801 (-9.56%)	20.18k
TRVNTrevena Inc	$ 0.2234 (-9.19%)	289.97k
DECADenali Capital Acquisition Corporation	$ 7.30 (-8.75%)	773
LDTCLeddarTech Holdings Inc	$ 0.874 (-8.58%)	500
ZCARZoomcar Holdings Inc	$ 0.167 (14.23%)	12.89M
NVDANVIDIA Corporation	$ 130.18 (-0.46%)	10.64M
KTRAKintara Therapeutics Inc	$ 0.3149 (14.55%)	10.31M
PBMPsyence Biomedical Ltd	$ 0.651 (8.50%)	8.48M
SPECSpectaire Holdings Inc	$ 0.6505 (91.32%)	5.39M